Option Care Health, Inc.
NASDAQ:OPCHMedical - Care Facilities
+$0.45 today
- Market cap
- $4.75B
- Beta
- 0.65
- P/E (TTM)
- 16.8
- EPS (TTM)
- $1.32
Volume 3.16M
Average 3.09M
OPCH Interest Income
Income earned on cash, deposits, and investments held by the company.
Option Care Health, Inc.NASDAQ: OPCH
Interest Income · Q3 FY2026 · quarter ended Sep 2026
Interest income remains negative
Q3 FY2026 interest income was $0, compared with $0 a year earlier. Trailing-twelve-month interest income was $0.
Context
- Interest income amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Interest income increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly interest income holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Income history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Interest Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Interest Income vs competitors
How OPCH compares with its peers on the latest reported figures
- OPCH's LTM Sep 2026 interest income of $0 is the 4th highest of the 6 companies compared; the peer median is $5.03M.
- Interest income amounts to 0.0% of revenue for OPCH, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $23.56M | -13.8% | +69.5% | 0.4% | |
| LTM Jun 2026 | $7.29M | -36.6% | +191.0% | 0.3% | |
| LTM Oct 2026 | $5.03M | +290.6% | +60.9% | 0.2% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding OPCH) | $5.03M | -13.8% | +69.5% | 0.2% | |
Competitors are the stored peer set for OPCH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.44B | 3.94B | 4.3B | 5B | 5.65B |
| Cost of Revenue | 2.66B | 3.08B | 3.32B | 3.99B | 4.63B |
| Gross Profit | 779.61M | 866.92M | 981.22M | 1.01B | 1.02B |
| Gross Margin | 22.7% | 22.0% | 22.8% | 20.3% | 18.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 525.71M | 566.12M | 607.43M | 630.25M | 682.45M |
| Operating Expenses | 588.77M | 626.69M | 666.63M | 691.16M | 682.45M |
| Depreciation & Amortization | 68.8M | 65.43M | 62.2M | 63.5M | 70.69M |
| EBITDA | 252.3M | 325.01M | 472.19M | 396.13M | 416.79M |
| EBITDA Margin | 7.3% | 8.2% | 11.0% | 7.9% | 7.4% |
| Operating Income | 190.84M | 240.23M | 314.6M | 321.83M | 337.91M |
| Operating Margin | 5.5% | 6.1% | 7.3% | 6.4% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 55.46M | 54.9M | 62.22M | 60.56M | 63.2M |
| Other Income / Expenses | (74.35M) | (34.46M) | 44.15M | (38.23M) | (55.01M) |
| Income Before Tax | 116.49M | 205.77M | 358.74M | 283.6M | 282.9M |
| Pre-Tax Margin | 3.4% | 5.2% | 8.3% | 5.7% | 5.0% |
| Income Tax Expense | (23.4M) | 55.21M | 91.65M | 71.78M | 75.32M |
| Net Income | 139.9M | 150.56M | 267.09M | 211.82M | 207.59M |
| Net Margin | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% |
| EPS (Basic) | 0.78 | 0.83 | 1.49 | 1.23 | 1.28 |
| EPS (Diluted) | 0.77 | 0.83 | 1.48 | 1.23 | 1.27 |
| Weighted Avg Shares | 179.86M | 181.11M | 178.97M | 171.57M | 162.1M |
| Weighted Avg Shares (Diluted) | 181.21M | 182.08M | 180.38M | 172.85M | 163.37M |
Option Care Health, Inc.
NASDAQ:OPCH
Intrinsic Alpha fair value
Locked
Current Price
$31.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.